Hikal Limited
Hikal Limited (HIKAL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
hikal.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 435 Cr | 448 Cr | 514 Cr | 407 Cr | 453 Cr | 448 Cr | 552 Cr | 380 Cr | 319 Cr | 494 Cr | 519 Cr | 403 Cr |
| Operating expenses (approx.) | 377 Cr | 383 Cr | 420 Cr | 349 Cr | 378 Cr | 376 Cr | 429 Cr | 355 Cr | 311 Cr | 412 Cr | 414 Cr | 366 Cr |
| EBITDA | 58 Cr | 65 Cr | 94 Cr | 58 Cr | 75 Cr | 72 Cr | 123 Cr | 25 Cr | 7 Cr | 83 Cr | 105 Cr | 37 Cr |
| OPM % | 13.2% | 14.5% | 18.4% | 14.3% | 16.5% | 16.1% | 22.3% | 6.6% | 2.3% | 16.7% | 20.3% | 9.2% |
| Other income | 0.99 Cr | 0.06 Cr | 0.46 Cr | 0.50 Cr | 0.40 Cr | 4 Cr | 0.50 Cr | 1 Cr | 2 Cr | 3 Cr | 7 Cr | 2 Cr |
| Interest | 13 Cr | 14 Cr | 15 Cr | 20 Cr | 19 Cr | 19 Cr | 18 Cr | 17 Cr | 15 Cr | 16 Cr | 15 Cr | 15 Cr |
| Depreciation | 29 Cr | 29 Cr | 32 Cr | 32 Cr | 32 Cr | 33 Cr | 38 Cr | 39 Cr | 41 Cr | 41 Cr | 42 Cr | 43 Cr |
| Profit before tax | 17 Cr | 22 Cr | 47 Cr | 7 Cr | 25 Cr | 24 Cr | 68 Cr | -30 Cr | -47 Cr | -9 Cr | 8 Cr | -10 Cr |
| Tax % | 25.4% | 25.3% | 28.2% | 26.1% | 26.2% | 27.7% | 26.5% | 26.3% | 25.7% | 35.9% | -73.5% | 25.3% |
| Net profit | 13 Cr | 16 Cr | 34 Cr | 5 Cr | 18 Cr | 17 Cr | 50 Cr | -22 Cr | -35 Cr | -6 Cr | 14 Cr | -7 Cr |
| EPS (₹) | ₹1.02 | ₹1.31 | ₹2.76 | ₹0.41 | ₹1.48 | ₹1.39 | ₹4.07 | ₹-1.82 | ₹-2.83 | ₹-0.48 | ₹1.17 | ₹-0.60 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,590 Cr | 1,507 Cr | 1,720 Cr | 1,943 Cr | 2,023 Cr | 1,785 Cr | 1,860 Cr | 1,713 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,291 Cr | 1,234 Cr | 1,398 Cr | 1,602 Cr | 1,766 Cr | 1,518 Cr | 1,531 Cr | 1,492 Cr | Sign in for TTM |
| EBITDA | 298 Cr | 273 Cr | 323 Cr | 341 Cr | 257 Cr | 267 Cr | 328 Cr | 220 Cr | Sign in for TTM |
| OPM % | 18.8% | 18.1% | 18.8% | 17.5% | 12.7% | 15.0% | 17.7% | 12.9% | Sign in for TTM |
| Other income | 2 Cr | 4 Cr | 5 Cr | 5 Cr | 5 Cr | 2 Cr | 5 Cr | 12 Cr | Sign in for TTM |
| Interest | 58 Cr | 52 Cr | 36 Cr | 31 Cr | 48 Cr | 56 Cr | 75 Cr | 62 Cr | Sign in for TTM |
| Depreciation | 93 Cr | 82 Cr | 85 Cr | 96 Cr | 109 Cr | 118 Cr | 134 Cr | 164 Cr | Sign in for TTM |
| Profit before tax | 149 Cr | 127 Cr | 206 Cr | 219 Cr | 105 Cr | 96 Cr | 124 Cr | -78 Cr | Sign in for TTM |
| Tax % | 30.9% | 33.3% | 35.5% | 26.6% | 25.6% | 27.1% | 26.7% | 37.7% | Sign in for TTM |
| Net profit | 103 Cr | 84 Cr | 133 Cr | 161 Cr | 78 Cr | 70 Cr | 91 Cr | -49 Cr | Sign in for TTM |
| EPS (₹) | ₹8.36 | ₹6.85 | ₹10.80 | ₹13.02 | ₹6.36 | ₹5.64 | ₹7.36 | ₹-3.96 | Sign in for TTM |
| Dividend payout % | — | — | — | 16.9% | 15.7% | 21.3% | 16.3% | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 25 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr | 25 Cr |
| Reserves | 732 Cr | 792 Cr | 909 Cr | 1,043 Cr | 1,109 Cr | 1,163 Cr | 1,238 Cr | 1,174 Cr |
| Borrowings | 600 Cr | 561 Cr | 515 Cr | 674 Cr | 748 Cr | 815 Cr | 762 Cr | 681 Cr |
| Other liabilities | 330 Cr | 390 Cr | 465 Cr | 471 Cr | 504 Cr | 485 Cr | 504 Cr | 485 Cr |
| Total liabilities | 1,686 Cr | 1,768 Cr | 1,913 Cr | 2,213 Cr | 2,385 Cr | 2,487 Cr | 2,529 Cr | 2,365 Cr |
| Fixed assets (net) | 710 Cr | 733 Cr | 711 Cr | 815 Cr | 948 Cr | 1,060 Cr | 1,357 Cr | 1,327 Cr |
| CWIP | 73 Cr | 152 Cr | 245 Cr | 285 Cr | 402 Cr | 414 Cr | 121 Cr | 95 Cr |
| Investments | 1 Cr | 0.68 Cr | 0.61 Cr | 11 Cr | 5 Cr | 5 Cr | 10 Cr | 10 Cr |
| Loans & advances | 0.50 Cr | 0.36 Cr | 0.23 Cr | 0.31 Cr | 0.24 Cr | 0.53 Cr | 0.50 Cr | 0.30 Cr |
| Inventories | 364 Cr | 312 Cr | 267 Cr | 329 Cr | 317 Cr | 304 Cr | 335 Cr | 358 Cr |
| Trade receivables | 350 Cr | 340 Cr | 486 Cr | 438 Cr | 442 Cr | 550 Cr | 522 Cr | 442 Cr |
| Cash & bank | 11 Cr | 32 Cr | 8 Cr | 11 Cr | 27 Cr | 13 Cr | 13 Cr | 10 Cr |
| Other assets | 175 Cr | 197 Cr | 196 Cr | 324 Cr | 244 Cr | 140 Cr | 171 Cr | 125 Cr |
| Total assets | 1,686 Cr | 1,768 Cr | 1,913 Cr | 2,213 Cr | 2,385 Cr | 2,487 Cr | 2,529 Cr | 2,365 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 294 Cr | 315 Cr | 187 Cr | 280 Cr | 302 Cr |
| Cash from investing | — | — | — | -284 Cr | -292 Cr | -174 Cr | -136 Cr | -145 Cr |
| Cash from financing | — | — | — | -6 Cr | -8 Cr | -27 Cr | -144 Cr | -160 Cr |
| Net cash flow | — | — | — | 4 Cr | 15 Cr | -14 Cr | 0.30 Cr | -3 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 20 Cr | 13 Cr | -17 Cr | 143 Cr | 154 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 27.4% | 21.9% | 16.7% | 14.3% | 8.2% | 7.6% | 9.8% | -0.9% |
| ROE % | 13.6% | 10.3% | 15.6% | 0.0% | 6.9% | 0.0% | 0.0% | -4.1% |
| Debtor days | 80 | 82 | 103 | 82 | 79 | 113 | 102 | 94 |
| Inventory days | 153 | 146 | 107 | 116 | 103 | 138 | 138 | 163 |
| Days payable | 67 | 94 | 92 | 88 | 102 | 127 | 125 | 121 |
| Cash conversion cycle | 165 | 134 | 118 | 110 | 81 | 124 | 115 | 136 |
| Debt / equity | 0.79 | 0.69 | 0.55 | 0.63 | 0.66 | 0.69 | 0.60 | 0.57 |
| Current ratio | 1.38 | 1.30 | 1.34 | 1.25 | 1.42 | 1.28 | 1.26 | 1.30 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 1.95 | 2.81 | 3.00 | 2.28 | 3.05 |
Compare with peers
Loading peers…